These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 22304683)

  • 1. The influence of the degree of esterification on the release characteristics of in situ gelling pectin formulations for oral sustained delivery of paracetamol.
    Miyazaki S; Murofushi H; Shimoyama T; Itoh K; Kobayashi M; Attwood D
    Pharm Dev Technol; 2013; 18(5):1259-64. PubMed ID: 22304683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In situ gelling pectin formulations for oral drug delivery at high gastric pH.
    Itoh K; Hirayama T; Takahashi A; Kubo W; Miyazaki S; Dairaku M; Togashi M; Mikami R; Attwood D
    Int J Pharm; 2007 Apr; 335(1-2):90-96. PubMed ID: 17141988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of variation of gastric pH on the gelation and release characteristics of in situ gelling pectin formulations.
    Itoh K; Kubo W; Fujiwara M; Hirayama T; Miyazaki S; Dairaku M; Togashi M; Mikami R; Attwood D
    Int J Pharm; 2006 Apr; 312(1-2):37-42. PubMed ID: 16473484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of gastric acidity and taste masking agent on in situ gelling pectin formulations for oral sustained delivery of acetaminophen.
    Itoh K; Kubo W; Fujiwara M; Watanabe H; Miyazaki S; Attwood D
    Biol Pharm Bull; 2006 Feb; 29(2):343-7. PubMed ID: 16462043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In situ gelling xyloglucan/pectin formulations for oral sustained drug delivery.
    Itoh K; Yahaba M; Takahashi A; Tsuruya R; Miyazaki S; Dairaku M; Togashi M; Mikami R; Attwood D
    Int J Pharm; 2008 May; 356(1-2):95-101. PubMed ID: 18295417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In situ gelling pectin formulations for oral sustained delivery of paracetamol.
    Kubo W; Konno Y; Miyazaki S; Attwood D
    Drug Dev Ind Pharm; 2004 Jul; 30(6):593-9. PubMed ID: 15285332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In situ gelling formulation based on methylcellulose/pectin system for oral-sustained drug delivery to dysphagic patients.
    Itoh K; Hatakeyama T; Shimoyama T; Miyazaki S; D'Emanuele A; Attwood D
    Drug Dev Ind Pharm; 2011 Jul; 37(7):790-7. PubMed ID: 21405940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of taste masking agents on in situ gelling pectin formulations for oral sustained delivery of paracetamol and ambroxol.
    Miyazaki S; Kubo W; Itoh K; Konno Y; Fujiwara M; Dairaku M; Togashi M; Mikami R; Attwood D
    Int J Pharm; 2005 Jun; 297(1-2):38-49. PubMed ID: 15907595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral liquid in situ gelling methylcellulose/alginate formulations for sustained drug delivery to dysphagic patients.
    Shimoyama T; Itoh K; Kobayashi M; Miyazaki S; D'Emanuele A; Attwood D
    Drug Dev Ind Pharm; 2012 Aug; 38(8):952-60. PubMed ID: 22283456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In situ gelling xyloglucan/alginate liquid formulation for oral sustained drug delivery to dysphagic patients.
    Itoh K; Tsuruya R; Shimoyama T; Watanabe H; Miyazaki S; D'Emanuele A; Attwood D
    Drug Dev Ind Pharm; 2010 Apr; 36(4):449-55. PubMed ID: 19788404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral sustained delivery of theophylline and cimetidine from in situ gelling pectin formulations in rabbits.
    Kubo W; Itoh K; Miyazaki S; Attwood D
    Drug Dev Ind Pharm; 2005 Sep; 31(8):819-25. PubMed ID: 16221617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and evaluation of gel formulations for oral sustained delivery to dysphagic patients.
    Miyazaki S; Takahashi A; Itoh K; Ishitani M; Dairaku M; Togashi M; Mikami R; Attwood D
    Drug Dev Ind Pharm; 2009 Jul; 35(7):780-7. PubMed ID: 19337871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral sustained delivery of ambroxol from in situ-gelling pectin formulations.
    Kubo W; Miyazaki S; Dairaku M; Togashi M; Mikami R; Attwood D
    Int J Pharm; 2004 Mar; 271(1-2):233-40. PubMed ID: 15129990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral sustained delivery of paracetamol from in situ gelling xyloglucan formulations.
    Miyazaki S; Endo K; Kawasaki N; Kubo W; Watanabe H; Attwood D
    Drug Dev Ind Pharm; 2003 Feb; 29(2):113-9. PubMed ID: 12648007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral sustained delivery of paracetamol from in situ-gelling gellan and sodium alginate formulations.
    Kubo W; Miyazaki S; Attwood D
    Int J Pharm; 2003 Jun; 258(1-2):55-64. PubMed ID: 12753753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-situ fast gelling formulation for oral sustained drug delivery of paracetamol to dysphagic patients.
    Sharma S; Sarkar G; Srestha B; Chattopadhyay D; Bhowmik M
    Int J Biol Macromol; 2019 Aug; 134():864-868. PubMed ID: 31102679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pectin gel vehicles for controlled fragrance delivery.
    Liu L; Chen G; Fishman ML; Hicks KB
    Drug Deliv; 2005; 12(3):149-57. PubMed ID: 16025844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pectin/Ethylcellulose as film coatings for colon-specific drug delivery: preparation and in vitro evaluation using 5-fluorouracil pellets.
    Wei H; Qing D; De-Ying C; Bai X; Fanli-Fang
    PDA J Pharm Sci Technol; 2007; 61(2):121-30. PubMed ID: 17479720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of modified in situ gelling oral liquid sustained release formulation of dextromethorphan.
    El Maghraby GM; Elzayat EM; Alanazi FK
    Drug Dev Ind Pharm; 2012 Aug; 38(8):971-8. PubMed ID: 22092113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of degree of esterification of pectin and calcium amount on drug release from pectin-based matrix tablets.
    Sungthongjeen S; Sriamornsak P; Pitaksuteepong T; Somsiri A; Puttipipatkhachorn S
    AAPS PharmSciTech; 2004 Feb; 5(1):E9. PubMed ID: 15198530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.